XML 22 R8.htm IDEA: XBRL DOCUMENT v3.23.3
10-K Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Current assets:                    
Cash and cash equivalents $ 10,919     $ 7,387       $ 4,880    
Fixed maturities, current 27,811     25,952       26,267    
Equity securities 165     953       1,881    
Premium receivables 7,883     7,083       5,681    
Self-funded receivables 3,756     4,663       4,010    
Other receivables 5,293     4,298       3,749    
Other current assets 5,358     5,281       4,654    
Total current assets 61,185     55,617       51,122    
Long-term investments:                    
Fixed maturities, long-term 816     752       632    
Other invested assets 6,118     5,685       5,225    
Property and equipment, net 4,248     4,316       3,919    
Goodwill 25,291     24,383       24,228 $ 21,691  
Other intangible assets 10,491     10,315       10,615    
Other noncurrent assets 2,329     1,687       1,715    
Total assets 110,478     102,755       97,456    
Current Liabilities:                    
Medical claims payable 16,176     15,596       13,518    
Other policyholder liabilities 5,681     5,933       5,521    
Unearned income 4,332     1,112       1,153    
Accounts payable and accrued expenses 5,983     5,607       4,970    
Short-term borrowings 0     265       275    
Current portion of long-term debt 799     1,500       1,599    
Other current liabilities 10,366     9,683       7,849    
Total current liabilities 43,337     39,696       34,885    
Long-term debt, less current portion 24,045     22,349       21,157    
Reserves for future policy benefits, noncurrent 807     803       753    
Deferred tax liabilities, net 1,779     2,015       2,815    
Other noncurrent liabilities 1,971     1,562       1,683    
Total liabilities 71,939     66,425       61,293    
Commitments and contingencies – Note 11              
Preferred stock, shares issued 0     0       0    
Preferred stock, shares outstanding 0     0       0    
Shareholders' equity                    
Preferred stock, without par value, shares authorized – 100,000,000; shares issued and outstanding – none $ 0     $ 0       $ 0    
Common stock, par value $0.01, shares authorized – 900,000,000; shares issued and outstanding – 234,906,987 and 237,958,067 2     2       2    
Additional paid-in capital 8,830     9,084       9,148    
Retained earnings 32,103     29,647       27,142    
Accumulated other comprehensive loss (2,512) $ (2,166)   (2,490) $ (2,779) $ (2,151)   (197) 150 $ (296)
Total Shareholders' Balance, beginning 38,423     36,243 $ 36,055     36,095    
Noncontrolling interests 116     87       68    
Total equity 38,539 $ 38,312 $ 37,460 36,330   $ 35,887 $ 36,059 36,163 $ 33,187 $ 31,693
Total liabilities and equity $ 110,478     $ 102,755       $ 97,456